These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial. Iro MA, Khatami A, Marshall AS, Pace D, Voysey M, McKenna J, Campbell D, Attard-Montalto S, Finn A, White C, Faust SN, Kent A, Heath PT, MacLeod E, Stanford E, Findlow H, Almond R, Bai X, Borrow R, Snape MD, Pollard AJ. Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661 [Abstract] [Full Text] [Related]
46. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age. Arístegui J, Dal-Ré R, Díez-Delgado J, Marés J, Casanovas JM, García-Corbeira P, De Frutos E, Van Esso D, Verdaguer J, De la Flor J, Moraga F, Boceta R, García-Martínez JA. Vaccine; 2003 Sep 08; 21(25-26):3593-600. PubMed ID: 12922087 [Abstract] [Full Text] [Related]
48. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR, Pentacel Study Group. Pediatrics; 2009 Jan 08; 123(1):301-12. PubMed ID: 19117896 [Abstract] [Full Text] [Related]
49. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. Shinefield H, Black S, Thear M, Coury D, Reisinger K, Rothstein E, Xu J, Hartzel J, Evans B, Digilio L, Schödel F, Brown ML, Kuter B, 013 Study Group for ProQuad. Pediatr Infect Dis J; 2006 Apr 08; 25(4):287-92. PubMed ID: 16567978 [Abstract] [Full Text] [Related]
52. Routine vaccines across the life span, 2003. Zimmerman RK, Middleton DB, Burns IT, Clover RD. J Fam Pract; 2003 Jan 01; 52(1 Suppl):S1-21. PubMed ID: 12556275 [Abstract] [Full Text] [Related]
53. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib). Martinón-Torres F, Boisnard F, Thomas S, Sadorge C, Borrow R, PRI02C study group. Vaccine; 2017 Jun 27; 35(30):3764-3772. PubMed ID: 28583305 [Abstract] [Full Text] [Related]
56. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers. Pedersen KB, Holck ME, Jensen AKG, Suppli CH, Benn CS, Krause TG, Sørup S. Scand J Public Health; 2020 Feb 27; 48(1):96-105. PubMed ID: 30024308 [No Abstract] [Full Text] [Related]
57. Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa®) and MMRV (ProQuad®) at 18 months of age. Kiely M, Billard MN, Toth E, Zafack JG, Landry M, Skowronski DM, De Serres G. Vaccine; 2018 Oct 29; 36(45):6688-6694. PubMed ID: 30269915 [Abstract] [Full Text] [Related]